Piezotronic Effect-Augmented Cu<sub>2-<i>x</i></sub>O-BaTiO<sub>3</sub> Sonosensitizers for Multifunctional Cancer Dynamic Therapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35699224.
- Also identified by DOI 10.1021/acsnano.2c01968.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ultrasound (US)-triggered sonodynamic therapy (SDT) based on semiconductor nanomaterials has attracted considerable attention for cancer therapy. However, most inorganic sonosensitizers suffer from low efficiency due to the rapid recombination of electron-hole pairs. Herein, the Cu<sub>2-<i>x</i></sub>O-BaTiO<sub>3</sub> piezoelectric heterostructure was fabricated as a sonosensitizer and chemodynamic agent, simultaneously, for improving reactive oxygen species (ROS) generation and cancer therapeutic outcome. Under US irradiation, the Cu<sub>2-<i>x</i></sub>O-BaTiO<sub>3</sub> heterojunction with a piezotronic effect exhibits high-performance singlet oxygen (<sup>1</sup>O<sub>2</sub>) and hydroxyl radical (•OH) generation to enhance SDT. Moreover, it possesses Fenton-like reaction activity to convert endogenous H<sub>2</sub>O<sub>2</sub> into •OH for chemodynamic therapy (CDT). The integration of SDT and CDT substantially boosts ROS generation and cellular mitochondria damage, and the in vitro and in vivo results demonstrate high cytotoxicity and tumor inhibition on murine refractory breast cancer. This work realizes improvement in cancer therapy using piezoelectric heterostructures with piezotronic effects.
Medical subject headings
- Ultrasonic Therapy
- Neoplasms
- Breast Neoplasms